Institutional Ownership
Sagimet Biosciences Inc
CUSIP 786700104COM SER ASGMTQ1 2026
13D / 13G Filings
21
Schedule 13D/13G on record
Beneficial Filers
11
Distinct reporting persons
Largest Stake
12.3%
Max % of class reported
Institutional Holders
84
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
21 filings · latest Dec 18, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Dec 18, 2025 | Kpcb Pandemic And Bio Defense Fund, LLC | 13G/A | — | — | SEC |
| 2 | Nov 14, 2025 | Woodline Partners LP | 13G/A | 4.8% | 1.50M | SEC |
| 3 | Aug 14, 2025 | Point72 Asset Management, L.P. | 13G/A | — | — | SEC |
| 4 | Aug 14, 2025 | Woodline Partners LP | 13G | 8.3% | 2.55M | SEC |
| 5 | Jun 24, 2025 | Ap11 Limited | 13G/A | 4.9% | 111.50M | SEC |
| 6 | May 20, 2025 | Ap11 Limited | 13G | 5.4% | 111.65M | SEC |
| 7 | May 15, 2025 | Point72 Asset Management, L.P. | 13G/A | 5.7% | 1.76M | SEC |
| 8 | May 13, 2025 | New Enterprise Associates 13, L.P. | 13G/A | 11.0% | 312.0K | SEC |
| 9 | Feb 14, 2025 | Blue Owl Capital Holdings LP | 13G/A | 11.0% | 1.32M | SEC |
| 10 | Nov 14, 2024 | Blue Owl Capital Holdings LP | 13G | 5.5% | 1.67M | SEC |
11 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Sagimet Biosciences Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Woodline Partners LP | 1.00M | $5.23M |
| 2 | Marshall Wace, LLP | 966.3K | $5.04M |
| 3 | Baker Bros. Advisors LP | 953.0K | $4.98M |
| 4 | Affinity Asset Advisors, LLC | 868.0K | $4.54M |
| 5 | Millennium Management LLC | 862.3K | $4.51M |
| 6 | Blackrock, Inc. | 799.9K | $4.18M |
| 7 | Hhlr Advisors, Ltd. | 724.8K | $3.79M |
| 8 | Renaissance Technologies LLC | 625.5K | $3.27M |
| 9 | D. E. Shaw & Co., Inc. | 411.6K | $2.15M |
| 10 | Blue Owl Capital Holdings LP | 333.9K | $1.74M |